financetom
Business
financetom
/
Business
/
Nvent Electric Insider Sold Shares Worth $312,644, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nvent Electric Insider Sold Shares Worth $312,644, According to a Recent SEC Filing
Nov 25, 2024 2:21 PM

04:52 PM EST, 11/25/2024 (MT Newswires) -- Robert J. van der Kolk, President of Electrical & Fastening Solutions, on November 22, 2024, sold 4,000 shares in Nvent Electric ( NVT ) for $312,644. Following the Form 4 filing with the SEC, van der Kolk has control over a total of 35,297 shares of the company, with 35,297 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1720635/000089706924002205/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Imaflex Operations Hit by Cybersecurity
Imaflex Operations Hit by Cybersecurity "Incident"
Feb 24, 2025
07:28 AM EST, 02/24/2025 (MT Newswires) -- Imaflex ( IFLXF ) , which works in packaging, over the weekend said a cybersecurity incident hit some of the company's systems. Imaflex ( IFLXF ) said it took immediate steps to contain and mitigate any potential impact on data and operations. The company launched an investigation and is working with third-party cybersecurity...
Bristol-Myers Squibb Colorectal Drug Accepted for Priority Review
Bristol-Myers Squibb Colorectal Drug Accepted for Priority Review
Feb 24, 2025
07:27 AM EST, 02/24/2025 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said Monday the US Food and Drug Administration has accepted its supplemental biologics license application for colorectal drug Opdivo plus Yervoy as a potential first-line treatment option for adult and pediatric patients. The application is for the treatment of adult and pediatric patients with unresectable or metastatic microsatellite...
BioCryst Pharmaceuticals Q4 Adjusted Loss Narrows, Revenue Rises
BioCryst Pharmaceuticals Q4 Adjusted Loss Narrows, Revenue Rises
Feb 24, 2025
07:27 AM EST, 02/24/2025 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) reported Q4 adjusted loss Monday of $0.13 per diluted share, narrower from a loss of $0.28 a year earlier. Four analysts polled by FactSet expected loss of $0.06. Revenue for the quarter ended Dec. 31 was $131.5 million, up from $93.4 million a year earlier. Analysts surveyed by...
Equitable Inks Reinsurance Deal With RGA And Plans To Boost Stake In AllianceBernstein: Details
Equitable Inks Reinsurance Deal With RGA And Plans To Boost Stake In AllianceBernstein: Details
Feb 24, 2025
Global life and health reinsurance entity Reinsurance Group of America, Incorporated ( RGA ) shares are trading higher in premarket on Monday. The company has reached an agreement with Equitable Holdings, Inc. ( EQH ) to reinsure a wide range of life insurance products. Under the terms of the deal, RGA is reinsuring 75% of Equitable’s in-force life insurance liabilities. The block...
Copyright 2023-2026 - www.financetom.com All Rights Reserved